On the problem of aspiration therapy of ovarian endometriomas
Aspiration therapy of ovarian endometriomas is discussed, noting a 43.2% relapse rate within 12 months and 37.3% pregnancy rate, emphasizing patient selection and hormone therapy compliance for favorable outcomes.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This article discusses disputable issues in aspiration therapy for ovarian endometriomas, contrasting it with sclerosing therapy. The authors report a relatively high 43.2% incidence of relapses within 12 months after sclerosing therapy, while pregnancy occurred in 37.3% of women during that period, with childbirth in all pregnancies. They state that aspiration therapy requires careful patient selection and that favorable outcomes depend in part on adherence to hormone therapy. This paper is centrally about endometriosis—specifically aspiration therapy and relapse/pregnancy outcomes in women with ovarian endometriomas.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00